Previous close | 1.7500 |
Open | 2.1500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 115.00 |
Expiry date | 2024-05-17 |
Day's range | 1.5500 - 2.1500 |
Contract range | N/A |
Volume | |
Open interest | 677 |
Consistent Revenue Growth Amidst Strategic Innovations and Market Expansions
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2024. The Company reported first quarter net sales of $1.889 billion, an increase of 3.2% over the prior year period, and an increase of 4.4% on a constant currency1 basis. Net earnings for the first quarter were $172.4 million, or $399.7 million on an adjusted1 basis.
Here is a sneak peek into how the five MedTech stocks, HOLX, ZBH, ILMN, TFX and BRKR, are expected to fare in their quarterly results slated to be released tomorrow.